Prison-based harm reduction services are needed to address the dual substance use disorder and infectious disease epidemics in US prisons

por Ohringer, Alison R., Ezer, Tamar, Serota, David P.
Publicado 2020

Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018

por Ohringer, Alison R., Serota, David P., McLean, Rachel L., Stockman, Lauren J., Watt, James P.
Publicado 2021

Immunological Treatment Failure Among Adult Patients Receiving Highly Active Antiretroviral Therapy in East Africa: A Systematic Review and Meta-Analysis

por Dessie, Getenet, Mulugeta, Henok, Wagnew, Fasil, Zegeye, Abriham, Kiross, Dessalegn, Negesse, Ayenew, Aynalem, Yared Asmare, Getaneh, Temsgen, Ohringer, Alison, Burrowes, Sahai
Publicado 2021

454. Impact of Covid-19 on Infectious Disease Fellows in the United States: A National Survey to Identify Targets for Intervention

por Balan, Shuba, Anjan, Shweta, Ohringer, Alison, Gonzales-Zamora, Jose, Weiss, Deborah Jones, Morris, Michele I, Alcaide, Maria L, Lichtenberger, Paola, Lichtenberger, Paola
Publicado 2021

Evidence for heterogeneity in China’s progress against pulmonary tuberculosis: uneven reductions in a major center of ongoing transmission, 2005–2017

por Li, Ting, Cheng, Qu, Li, Charles, Stokes, Everleigh, Collender, Philip, Ohringer, Alison, Li, Xintong, Li, Jing, Zelner, Jonathan L., Liang, Song, Yang, Changhong, Remais, Justin V., He, Jin’ge
Publicado 2019